Newborn screening searches for genetic markers in blood or heel prick samples to detect health issues in infants, enabling crucial early intervention that improves long-term outcomes. The advent of innovative PCR-based techniques that streamline and enhance existing approaches, such as dry PCR, promises to further improve newborn screening laboratory workflows.
Download this article from The Scientist’s Creative Services Team and Revvity to discover how dry PCR enables more effective newborn screening workflows for spinal muscular atrophy (SMA) and severe combined immunodeficiency syndrome (SCID).
